Which has grown faster, ABCL or INDV?

Over the past five years, INDV grew revenue faster — ABCL at a -31.78% CAGR versus INDV at 13.88%.

Does ABCL or INDV pay a bigger dividend?

INDV pays a dividend (1.32% yield), while ABCL has no payments in the available dividend history.

Is ABCL or INDV more profitable?

INDV runs the higher net margin — ABCL at -248.83% versus INDV at 26.65%.

How have ABCL and INDV total returns compared?

Over the past 5 years, ABCL delivered -3.57% and INDV delivered 19.65% annualized total return. Past performance doesn't predict future results.

AbCellera Biologics Inc. (ABCL) vs Indivior Pharmaceuticals Inc (INDV)

A side-by-side comparison of AbCellera Biologics Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABCL

AbCellera Biologics Inc.

$4.01B

$13.14HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

INDV

Indivior Pharmaceuticals Inc

$4.46B

$35.76HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — ABCL vs INDV

growth of $100 · dividends reinvested · last 6y

ABCL -76.6% (-21.5%/yr)INDV +414.1% (+31.4%/yr)INDV compounded faster over this window

Log scale — wide-divergence pair

ABCL INDV

ABCL vs INDV: by the numbers

•INDV is the larger company ($4.46B vs $4.01B market cap).
•INDV is profitable (26.65% net margin) while ABCL runs a net loss (-248.83%).
•INDV grew revenue faster over the past five years (13.88% vs -31.78% CAGR).
•INDV pays a dividend (1.32% yield), while ABCL has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ABCL	INDV
P/E ratio	N/A	12.82
Forward P/E	N/A	8.47
P/S ratio	60.62	3.35
P/B ratio	4.48	N/A
EV / EBITDA	N/A	8.91

Profitability

Metric	ABCL	INDV
Gross margin	61.64%	83.86%
Operating margin	-288.98%	21.39%
Net margin	-248.83%	26.65%
ROE	-18.38%	N/A
ROIC	-17.95%	N/A

Dividends

Metric	ABCL	INDV
Dividend yield	N/A	1.32%
Payout ratio	N/A	17.03%

Growth (annualized)

Metric	ABCL	INDV
Revenue CAGR (5Y)	-31.78%	13.88%
Total return CAGR (5Y)	-3.57%	19.65%

Frequently asked

Which has grown faster, ABCL or INDV?: Over the past five years, INDV grew revenue faster — ABCL at a -31.78% CAGR versus INDV at 13.88%.
Does ABCL or INDV pay a bigger dividend?: INDV pays a dividend (1.32% yield), while ABCL has no payments in the available dividend history.
Is ABCL or INDV more profitable?: INDV runs the higher net margin — ABCL at -248.83% versus INDV at 26.65%.
How have ABCL and INDV total returns compared?: Over the past 5 years, ABCL delivered -3.57% and INDV delivered 19.65% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABCL analysis Full INDV analysis Interactive comparison tool

Dig into the metrics

Indivior Pharmaceuticals P/E ratio Indivior Pharmaceuticals dividend yield AbCellera Biologics ROE Indivior Pharmaceuticals ROE AbCellera Biologics operating margin Indivior Pharmaceuticals operating margin AbCellera Biologics revenue growth Indivior Pharmaceuticals revenue growth AbCellera Biologics free cash flow Indivior Pharmaceuticals free cash flow

AbCellera Biologics & Indivior Pharmaceuticals appear in these rankings

Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.